Hasil Pencarian - Dan‐xia Lu

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients

    Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients oleh Hong‐xia Tian, Zhi‐hong Chen, Guang‐Ling Jie, Zhen Wang, Hong‐hong Yan, Si‐pei Wu, Shui‐lian Zhang, Dan‐xia Lu, Xu‐chao Zhang, Yi‐long Wu

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma

    Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma oleh Kai Yin, Hui‐Bo Feng, Lin‐Lin Li, Yu Chen, Zhi Xie, Zhi‐Yi Lv, Wei‐Bang Guo, Dan‐Xia Lu, Xue‐Ning Yang, Wen‐Qing Yan, Yi‐Long Wu, Xu‐Chao Zhang

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    An integrated biomarker of PD‐L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases

    An integrated biomarker of PD‐L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of b... oleh Lin‐Lin Li, De‐Xiang Zhou, Ming Lu, Dong Zhou, Xiao‐Feng Lin, Yu Chen, Kai Yin, Hui‐Bo Feng, Wei‐Bang Guo, Zhi Xie, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Shui‐Lian Zhang, Xu‐Chao Zhang

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma

    PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma oleh Yu-Min Zhong, Yu-Min Zhong, Yu-Min Zhong, Kai Yin, Kai Yin, Yu Chen, Yu Chen, Zhi Xie, Zhi Xie, Zhi-Yi Lv, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Shui-Lian Zhang, Dan-Xia Lu, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma

    Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma oleh Yu‐Min Zhong, Ji Chen, Jie Jiang, Wen‐Bin Zhou, Ling‐Ling Gao, Shui‐Lian Zhang, Wen‐Qing Yan, Yu Chen, Dong‐Kun Zhang, Dan‐Xia Lu, Zhi‐Yi Lv, Zhi Xie, Ying Huang, Wei‐Bang Guo, Bin‐Chao Wang, Jin‐Ji Yang, Xue‐Ning Yang, Yi‐Long Wu, Xu‐Chao Zhang

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

    High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer oleh Hui‐Bo Feng, Yu Chen, Zhi Xie, Jie Jiang, Yu‐Min Zhong, Wei‐Bang Guo, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Hong‐Ling Liang, Fang‐Ping Xu, Jin‐Ji Yang, Xue‐Ning Yang, Qing Zhou, Dong‐Kun Zhang, Zhou Zhang, Shao‐Kun Chuai, Heng‐Hui Zhang, Yi‐Long Wu, Xu‐Chao Zhang

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: